v3.24.1.1.u2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net Loss $ (3,222,216) $ (3,204,819)
Adjustments to reconcile change in net loss to net cash used in operating activities:    
Depreciation and amortization 414,177 525,631
Stock-based compensation expense 760,738 103,809
Value of common stock issued in exchange for consulting services 71,940
Changes in operating assets and liabilities which used cash:    
Accounts Receivable 15,000 (29,205)
Prepaid expenses and other current assets (73,476) 386,086
Accounts payable (7,063) (27,794)
Accrued compensation (900) (92,856)
Deferred revenue (52,083) (236,692)
Accrued and other liabilities 6,459 (79,595)
Net cash and cash equivalents used in operating activities (2,159,364) (2,583,495)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,166) (5,554)
Investment in capitalized software (227,600) (288,209)
Net cash and cash equivalents used in investing activities (228,766) (293,763)
Cash flows from Financing Activity    
Issuance of common stock - net of issuance costs 1,850,501
Net cash and cash equivalents provided by financing activity 1,850,501
Net decrease in cash and cash equivalents (2,388,130) (1,026,757)
Cash and cash equivalents - Beginning of period 5,360,661 7,155,367
Cash and cash equivalents - End of period $ 2,972,531 $ 6,128,610

Source